Showing results (1531-1540 of 1,618) with videos related to
Sort By:
Pageof 162
Eneuro|November 28, 2023
Internet-Connected Cortical Organoids for Project-Based Stem Cell and Neuroscience EducationMatthew A T Elliott, Hunter E Schweiger, Ash Robbins, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|January 30, 2020
Study design considerations for sleep-disordered breathing devicesEric A Mann, Srinivas Nandkumar, Nancy Addy, et al.Journal of Clinical Sleep Medicine : JCSM : Official Publication of the American Academy of Sleep Medicine|April 4, 2018
The Risk of Fatigue and Sleepiness in the Ridesharing Industry: An American Academy of Sleep Medicine Position StatementMichael Berneking, Ilene M Rosen, Douglas B Kirsch, et al.Neuron|September 25, 2012
Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsyRaymund Y K Pun, Isaiah J Rolle, Candi L Lasarge, et al.Journal of Geophysical Research|June 20, 1989
SAGE II aerosol data validation based on retrieved aerosol model size distribution from SAGE II aerosol measurementsP H Wang, M P McCormick, L R McMaster, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 20, 2013
Predicting drug responsiveness in human cancers using genetically engineered miceJerry Usary, Wei Zhao, David Darr, et al.Nature Cancer|February 5, 2022
Resistance to natural killer cell immunosurveillance confers a selective advantage to polyclonal metastasisHin Ching Lo, Zhan Xu, Ik Sun Kim, et al.Cancer Cell|January 21, 2015
The osteogenic niche promotes early-stage bone colonization of disseminated breast cancer cellsHai Wang, Cuijuan Yu, Xia Gao, et al.The Journal of Investigative Dermatology|July 15, 2015
Nitric Oxide-Releasing Nanoparticles Prevent Propionibacterium acnes-Induced Inflammation by Both Clearing the Organism and Inhibiting Microbial Stimulation of the Innate Immune ResponseMin Qin, Angelo Landriscina, Jamie M Rosen, et al.Cancer Research Communications|February 14, 2022
Tumor suppressor PLK2 may serve as a biomarker in triple-negative breast cancer for improved response to PLK1 therapeuticsYang Gao, Elena B Kabotyanski, Jonathan H Shepherd, et al.Pageof 162